WATSON 415 (Estropipate 1.5 mg)

Pill imprint WATSON 415 has been identified as Estropipate 1.5 mg.

Estropipate is used in the treatment of postmenopausal symptoms; osteoporosis; oophorectomy; primary ovarian failure; atrophic vaginitis (and more), and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 1.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Estropipate

Imprint:

WATSON 415

Strength:

1.5 mg

Color:

Orange

Shape:

Round

Availability:

Prescription only

Drug Class:

Estrogens

Pregnancy Category:

X - Not for use in pregnancy

CSA Schedule:

Not a controlled drug

Manufacturer:

Watson Pharmaceuticals

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.